Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Gou X, Anurag M, Lei JT, Kim BJ, et al. Transcriptional reprogramming differentiates active from inactive ESR1 fusions in endocrine therapy-refractory metastatic breast cancer. Cancer Res 2021 Oct 28. pii: 0008-5472.CAN-21-1256.
PMID: 34711608


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016